Ausgabe 3/2010
Inhalt (17 Artikel)
‘Selling sickness: influence on influence’, what constitutes good prescribing in 2010?
J. W. Foppe van Mil, Martine E. C. van Eijk
Pharmacotherapeutic review and update of idiopathic nephrotic syndrome in children
Silvia Manrique-Rodríguez, Cecilia M. Fernandez-Llamazares, Maria Sanjurjo-Saez
Detection of adverse drug reactions through the minimum basic data set
Antonio Salmerón-García, José Cabeza Barrera, Maria José Vergara Pavón, Eva Román Márquez, Sol Cortés de Miguel, Inmaculada Vallejo-Rodríguez, Susana Raya García, Emilia Casado Fernández
Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy
Juraporn Pongwecharak, Tarakamon Treeranurat
Views of parents and pharmacists following participation in a paediatric pharmacovigilance study
Mansour Tobaiqy, Derek Stewart, Peter J. Helms, Christine M. Bond, Amanda Jane Lee, James McLay
Community pharmacists’ views on adverse drug reactions reporting in Malaysia: a pilot study
Kang-Nee Ting, Dane Michael Stratton-Powell, Claire Anderson
Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity
Geoffrey C. Wall, Jane E. DeWitt, Sally Haack, Anisa Fornoff, Darla K. Eastman, Carrie F. Koenigsfeld
Substitution of corticosteroid with everolimus after lung transplantation: a pediatric case report
Thibaut Caruba, Vanida Brunie, Véronique Bousseau, Romain Guillemain, Patrice Prognon, Dominique Bégué, Brigitte Sabatier
Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease
T. Bauters, V. Bordon, V. Van de Velde, S. Van Lancker, H. Robays, Y. Benoit, G. Laureys
Use of simulated patients to assess the clinical and communication skills of community pharmacists
Marjorie C. Weiss, Anneka Booth, Bethan Jones, Sarah Ramjeet, Eva Wong
Classification of drug-related problems with new prescriptions using a modified PCNE classification system
Patrick M. Eichenberger, Markus L. Lampert, Irene Vogel Kahmann, J. W. Foppe van Mil, Kurt E. Hersberger
Cardiovascular risk screening program in Australian community pharmacies
Gregory M. Peterson, Kimbra D. Fitzmaurice, Helen Kruup, Shane L. Jackson, Rohan L. Rasiah
Community pharmacists’ perceptions of medicines use reviews and quality assurance by peer review
Geoffrey Harding, Michael Wilcock
Access to children’s medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007
Rajan Ragupathy, June Tordoff, Pauline Norris, David Reith
Evaluating categorisation and clinical relevance of drug-related problems in medication reviews
Anne Gerd Granas, Christian Berg, Vidar Hjellvik, Cecilie Haukereid, Arvid Kronstad, Hege S. Blix, Bente Kilhovd, Kirsten K. Viktil, Anne Marie Horn
Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital
Franky Buyle, Dirk Vogelaers, Renaat Peleman, Georges Van Maele, Hugo Robays